Natco Pharma gains on launching Chlorantraniliprole combination Agro Products in India
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Natco Pharma is currently trading at Rs. 618.05, up by 5.55 points or 0.91% from its previous closing of Rs. 612.50 on the BSE.
The scrip opened at Rs. 617.95 and has touched a high and low of Rs. 621.85 and Rs. 613.60 respectively. So far 16490 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 942.15 on 17-Jan-2022 and a 52 week low of Rs. 593.20 on 28-Sep-2022.
Last one week high and low of the scrip stood at Rs. 622.80 and Rs. 593.20 respectively. The current market cap of the company is Rs. 11268.34 crore.
The promoters holding in the company stood at 48.80%, while Institutions and Non-Institutions held 26.95% and 24.25% respectively.
Natco Pharma has launched two Chlorantraniliprole (CTPR) pesticide formulated combination products under the brand names: NATVOL: Chlorantraniliprole 8.8% + Thiamethoxam 17.5% SC; and NATLIGO: Chlorantraniliprole 9.3% + Lambda-cyhalothrin 4.6% ZC. Both products are broad-spectrum, foliar insecticides used across wide range of crops. Syngenta markets these combination products under brand names Voliam Flexi and Ampligo.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
